e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Genetics and immunology of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Volatile markers of pulmonary tuberculosis in the breath
M. Phillips, R. N. Cataneo, R. Condos, G. A. Ring Erickson, J. Greenberg, V. La Bombardi (Fort Lee, Valhalla, New York, Woodinville, United States Of America)
Source:
Annual Congress 2004 - Genetics and immunology of tuberculosis
Session:
Genetics and immunology of tuberculosis
Session type:
Oral Presentation
Number:
2924
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Phillips, R. N. Cataneo, R. Condos, G. A. Ring Erickson, J. Greenberg, V. La Bombardi (Fort Lee, Valhalla, New York, Woodinville, United States Of America). Volatile markers of pulmonary tuberculosis in the breath. Eur Respir J 2004; 24: Suppl. 48, 2924
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis
Source: Eur Respir J 2006; 27: 929-936
Year: 2006
Sensors for detecting pulmonary diseases from exhaled breath
Source: Eur Respir Rev, 28 (152) 190011; 10.1183/16000617.0011-2019
Year: 2019
Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
The role of galactomannan in exhaled breath condensate in detecting pulmonary aspergillosis in patients with exacerbated COPD
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012
Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Detecting active pulmonary tuberculosis with a breath test using nanomaterial-based sensors
Source: Eur Respir J 2014; 43: 1522-1525
Year: 2014
Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Volatile organic compounds (VOC) in exhaled breath of patients with COPD
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Exhaled breath condensate markers in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 334s
Year: 2005
Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases
Source: Annual Congress 2009 - Lung function in adults and children
Year: 2009
Value of exhaled volatile organic compounds in monitoring airway disease
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013
Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF
Source: Eur Respir J 2006; 28: Suppl. 50, 353s
Year: 2006
Exhaled breath CO and induced sputum in noninvasive assessment of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 457s
Year: 2003
Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008
Exhaled volatile organic compounds in idiopathic pulmonary fibrosis and disease progression
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020
Detection and characterisation of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients
Source: Eur Respir J, 58 (2) 2003024; 10.1183/13993003.03024-2020
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept